As part of the SBIR Phase I effort, Nanoparticle Biochem Inc has successfully completed detailed therapeutic efficacy studies of NBI-29 (GA-198AuNPSBIR Phase II 2010 Department of Health and Human Services
In this Phase I SBIR contract, Nanoparticle Biochem Inc (NBI) proposes to develop commercially viable synthetic methodology for the production of multifunctional gold Nanoparticle-bombesin conjugate. ...SBIR Phase I 2008 Department of Health and Human Services
The objective of this proposal is to develop nanoparticulate therapeutic products from the readily injectable Gold-198 (Au-198) nanoconstructs invented at the University of Missouri and licensed to Na ...SBIR Phase I 2008 Department of Health and Human Services
NANOPARTICLE BIOCHEM, INC.
| 2814 WILD PLUM CT.
COLUMBIA, MO, 65201-
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|